Healthcare provider profile · identity verified

Devin Edwin Shahverdian, M.D.

Internal Medicine · PHOENIX, AZ · NPI 1972786143

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	694	323
Lisinopril	Lisinopril	379	168
Amlodipine Besylate	Amlodipine Besylate	366	169
Rosuvastatin Calcium	Rosuvastatin Calcium	343	148
Losartan Potassium	Losartan Potassium	327	150
Metformin Hcl	Metformin Hcl	244	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	221	44
Levothyroxine Sodium	Levothyroxine Sodium	218	101
Albuterol Sulfate Hfa	Albuterol Sulfate	196	121
Pantoprazole Sodium	Pantoprazole Sodium	186	73
Metformin Hcl Er	Metformin Hcl	182	82
Trazodone Hcl	Trazodone Hcl	162	63
Meloxicam	Meloxicam	149	76
Tamsulosin Hcl	Tamsulosin Hcl	144	70
Omeprazole	Omeprazole	143	74
Metoprolol Tartrate	Metoprolol Tartrate	133	63
Hydrochlorothiazide	Hydrochlorothiazide	131	65
Glipizide	Glipizide	130	56
Humulin N	Insulin Nph Human Isophane	126	39
Prednisone	Prednisone	120	106
Finasteride	Finasteride	115	46
Alendronate Sodium	Alendronate Sodium	110	53
Simvastatin	Simvastatin	109	58
Gabapentin	Gabapentin	107	58
Ibuprofen	Ibuprofen	106	51
Atenolol	Atenolol	105	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	53
Potassium Chloride	Potassium Chloride	92	56
Naproxen	Naproxen	90	56
Pradaxa	Dabigatran Etexilate Mesylate	87	36
Terazosin Hcl	Terazosin Hcl	83	35
Bisoprolol Fumarate	Bisoprolol Fumarate	82	39
Furosemide	Furosemide	82	48
Azithromycin	Azithromycin	80	77
Jardiance	Empagliflozin	77	35
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	77	35
Ozempic	Semaglutide	66	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	63	61
Amoxicillin	Amoxicillin	59	59
Tramadol Hcl	Tramadol Hcl	59	18
Lactulose	Lactulose	57	29
Hydralazine Hcl	Hydralazine Hcl	53	22
Hydrocortisone	Hydrocortisone	53	29
Wixela Inhub	Fluticasone Propion/Salmeterol	52	26
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	51	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	50	22
Baclofen	Baclofen	49	17
Carvedilol	Carvedilol	49	26
Humulin R	Insulin Regular, Human	48	20
Sertraline Hcl	Sertraline Hcl	48	20
Doxycycline Monohydrate	Doxycycline Monohydrate	45	44
Lorazepam	Lorazepam	45	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Allopurinol	Allopurinol	42	19
Alprazolam	Alprazolam	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	18
Triamcinolone Acetonide	Triamcinolone Acetonide	42	30
Duloxetine Hcl	Duloxetine Hcl	41	25
Glipizide-Metformin	Glipizide/Metformin Hcl	41	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	19
Humulin N Kwikpen	Insulin Nph Human Isophane	38	13
Acetaminophen-Codeine	Acetaminophen With Codeine	36	24
Citalopram Hbr	Citalopram Hydrobromide	29	14
Escitalopram Oxalate	Escitalopram Oxalate	29	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	14
Fluticasone Propionate	Fluticasone Propionate	28	13
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Spironolactone	Spironolactone	26	11
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	11
Famotidine	Famotidine	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Ofloxacin	Ofloxacin	23	23
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	23	11
Fluoxetine Hcl	Fluoxetine Hcl	22	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Acyclovir	Acyclovir	21	11
Cefadroxil	Cefadroxil	21	21
Colchicine	Colchicine	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Topiramate	Topiramate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Pravastatin Sodium	Pravastatin Sodium	19	12
Alvesco	Ciclesonide	18	suppressed
Cephalexin	Cephalexin	18	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Donepezil Hcl	Donepezil Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Ondansetron Odt	Ondansetron	18	17
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Victoza 2-Pak	Liraglutide	18	suppressed
Ciclopirox	Ciclopirox	17	11
Digoxin	Digoxin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	11
Fluconazole	Fluconazole	16	16
Glipizide Er	Glipizide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Liraglutide	Liraglutide	15	suppressed
Nystatin	Nystatin	15	11
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Metoprolol Succinate	Metoprolol Succinate	14	suppressed
Naloxone Hcl	Naloxone Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Eliquis	Apixaban	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error